| Andrew P Ortega, MD | |
|
902 Bandera Rd, San Antonio, TX 78228-4923 | |
| (210) 431-4503 | |
| (210) 431-4531 |
| Full Name | Andrew P Ortega |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 34 Years |
| Location | 902 Bandera Rd, San Antonio, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225003122 | NPI | - | NPPES |
| 101522404 | Medicaid | TX | |
| 080180909 | Other | TX | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | J1474 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gmg Health Systems Associates Pa | 8123932647 | 100 |
News Archive
Hospira, the world's leading provider of injectable drugs and infusion technologies, today received a positive opinion from the European Medicines Agency Committee for Medicinal Products for Human Use, recommending the European Commission approval of Inflectra (infliximab) for rheumatoid arthritis, inflammatory bowel disease and plaque psoriasis.
The scientific benefits of whole genome sequencing at the Translational Genomics Research Institute will be presented at the 14th International Myeloma Workshop, April 3-7 at the Kyoto International Conference Center.
Cosmetic companies have started developing and selling products designed to harness the skin microbiome to help treat a range of skin conditions from acne to eczema.
MicroStockProfit.com announces an investment report featuring Cardium Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A vaccine used to protect travelers from cholera, an infection characterized by diarrhea and severe dehydration, could also be used effectively among those living in cholera-prone (endemic) areas, according to a research study by Ira Longini and colleagues published in PLoS Medicine.
› Verified 1 days ago
| Entity Name | Gmg Health Systems Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023030160 PECOS PAC ID: 8123932647 Enrollment ID: O20040121001049 |
News Archive
Hospira, the world's leading provider of injectable drugs and infusion technologies, today received a positive opinion from the European Medicines Agency Committee for Medicinal Products for Human Use, recommending the European Commission approval of Inflectra (infliximab) for rheumatoid arthritis, inflammatory bowel disease and plaque psoriasis.
The scientific benefits of whole genome sequencing at the Translational Genomics Research Institute will be presented at the 14th International Myeloma Workshop, April 3-7 at the Kyoto International Conference Center.
Cosmetic companies have started developing and selling products designed to harness the skin microbiome to help treat a range of skin conditions from acne to eczema.
MicroStockProfit.com announces an investment report featuring Cardium Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A vaccine used to protect travelers from cholera, an infection characterized by diarrhea and severe dehydration, could also be used effectively among those living in cholera-prone (endemic) areas, according to a research study by Ira Longini and colleagues published in PLoS Medicine.
› Verified 1 days ago
| Entity Name | South Texas Ancillary Services Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063670289 PECOS PAC ID: 1456677087 Enrollment ID: O20150226000223 |
News Archive
Hospira, the world's leading provider of injectable drugs and infusion technologies, today received a positive opinion from the European Medicines Agency Committee for Medicinal Products for Human Use, recommending the European Commission approval of Inflectra (infliximab) for rheumatoid arthritis, inflammatory bowel disease and plaque psoriasis.
The scientific benefits of whole genome sequencing at the Translational Genomics Research Institute will be presented at the 14th International Myeloma Workshop, April 3-7 at the Kyoto International Conference Center.
Cosmetic companies have started developing and selling products designed to harness the skin microbiome to help treat a range of skin conditions from acne to eczema.
MicroStockProfit.com announces an investment report featuring Cardium Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A vaccine used to protect travelers from cholera, an infection characterized by diarrhea and severe dehydration, could also be used effectively among those living in cholera-prone (endemic) areas, according to a research study by Ira Longini and colleagues published in PLoS Medicine.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew P Ortega, MD 720 Pleasanton Rd, San Antonio, TX 78214-1306 Ph: (210) 921-3800 | Andrew P Ortega, MD 902 Bandera Rd, San Antonio, TX 78228-4923 Ph: (210) 431-4503 |
News Archive
Hospira, the world's leading provider of injectable drugs and infusion technologies, today received a positive opinion from the European Medicines Agency Committee for Medicinal Products for Human Use, recommending the European Commission approval of Inflectra (infliximab) for rheumatoid arthritis, inflammatory bowel disease and plaque psoriasis.
The scientific benefits of whole genome sequencing at the Translational Genomics Research Institute will be presented at the 14th International Myeloma Workshop, April 3-7 at the Kyoto International Conference Center.
Cosmetic companies have started developing and selling products designed to harness the skin microbiome to help treat a range of skin conditions from acne to eczema.
MicroStockProfit.com announces an investment report featuring Cardium Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A vaccine used to protect travelers from cholera, an infection characterized by diarrhea and severe dehydration, could also be used effectively among those living in cholera-prone (endemic) areas, according to a research study by Ira Longini and colleagues published in PLoS Medicine.
› Verified 1 days ago
Dr. Obinna C. Uzowulu, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 22250 Bulverde Rd, Suite 111, San Antonio, TX 78261 Phone: 210-899-4490 Fax: 210-592-8195 | |
Dr. Salima Jaffer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 22800 Bulverde Rd Apt 2202, San Antonio, TX 78261 Phone: 210-878-4033 | |
David A. Ramos, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3110 Nogalitos, Suite 105, San Antonio, TX 78225 Phone: 210-533-0257 Fax: 210-534-0890 | |
Patricia May B. Lacsina, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 903 W Martin St, San Antonio, TX 78207 Phone: 210-358-3441 Fax: 210-358-5944 | |
Adriana S Sanchez, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8300 Floyd Curl Dr, San Antonio, TX 78229 Phone: 210-450-9000 | |
Dr. Aneela N. Hussain, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 4610 E Southcross Blvd, San Antonio, TX 78222 Phone: 210-648-1491 | |
Javier C Bocanegra, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1616 Callaghan Rd, San Antonio, TX 78228 Phone: 210-435-1218 Fax: 210-435-3162 |